# Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C

> **NCT04159246** · — · UNKNOWN · sponsor: **Mohamed Saad** · enrollment: 30 (estimated)

## Conditions studied

- HCV Infection

## Interventions

- **DEVICE:** Optical coherence tomography angiography
- **DRUG:** Sofosbuvir (Sovaldi)

## Key facts

- **NCT ID:** NCT04159246
- **Lead sponsor:** Mohamed Saad
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-10
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-11-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159246, "Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04159246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*